Cargando…
Scorpion venom components as potential candidates for drug development
Scorpions are well known for their dangerous stings that can result in severe consequences for human beings, including death. Neurotoxins present in their venoms are responsible for their toxicity. Due to their medical relevance, toxins have been the driving force in the scorpion natural compounds r...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130864/ https://www.ncbi.nlm.nih.gov/pubmed/25432067 http://dx.doi.org/10.1016/j.toxicon.2014.11.233 |
_version_ | 1783517107656327168 |
---|---|
author | Ortiz, Ernesto Gurrola, Georgina B. Schwartz, Elisabeth Ferroni Possani, Lourival D. |
author_facet | Ortiz, Ernesto Gurrola, Georgina B. Schwartz, Elisabeth Ferroni Possani, Lourival D. |
author_sort | Ortiz, Ernesto |
collection | PubMed |
description | Scorpions are well known for their dangerous stings that can result in severe consequences for human beings, including death. Neurotoxins present in their venoms are responsible for their toxicity. Due to their medical relevance, toxins have been the driving force in the scorpion natural compounds research field. On the other hand, for thousands of years, scorpions and their venoms have been applied in traditional medicine, mainly in Asia and Africa. With the remarkable growth in the number of characterized scorpion venom components, several drug candidates have been found with the potential to tackle many of the emerging global medical threats. Scorpions have become a valuable source of biologically active molecules, from novel antibiotics to potential anticancer therapeutics. Other venom components have drawn attention as useful scaffolds for the development of drugs. This review summarizes the most promising candidates for drug development that have been isolated from scorpion venoms. |
format | Online Article Text |
id | pubmed-7130864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71308642020-04-08 Scorpion venom components as potential candidates for drug development Ortiz, Ernesto Gurrola, Georgina B. Schwartz, Elisabeth Ferroni Possani, Lourival D. Toxicon Article Scorpions are well known for their dangerous stings that can result in severe consequences for human beings, including death. Neurotoxins present in their venoms are responsible for their toxicity. Due to their medical relevance, toxins have been the driving force in the scorpion natural compounds research field. On the other hand, for thousands of years, scorpions and their venoms have been applied in traditional medicine, mainly in Asia and Africa. With the remarkable growth in the number of characterized scorpion venom components, several drug candidates have been found with the potential to tackle many of the emerging global medical threats. Scorpions have become a valuable source of biologically active molecules, from novel antibiotics to potential anticancer therapeutics. Other venom components have drawn attention as useful scaffolds for the development of drugs. This review summarizes the most promising candidates for drug development that have been isolated from scorpion venoms. Elsevier Ltd. 2015-01 2014-11-26 /pmc/articles/PMC7130864/ /pubmed/25432067 http://dx.doi.org/10.1016/j.toxicon.2014.11.233 Text en Copyright © 2014 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ortiz, Ernesto Gurrola, Georgina B. Schwartz, Elisabeth Ferroni Possani, Lourival D. Scorpion venom components as potential candidates for drug development |
title | Scorpion venom components as potential candidates for drug development |
title_full | Scorpion venom components as potential candidates for drug development |
title_fullStr | Scorpion venom components as potential candidates for drug development |
title_full_unstemmed | Scorpion venom components as potential candidates for drug development |
title_short | Scorpion venom components as potential candidates for drug development |
title_sort | scorpion venom components as potential candidates for drug development |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130864/ https://www.ncbi.nlm.nih.gov/pubmed/25432067 http://dx.doi.org/10.1016/j.toxicon.2014.11.233 |
work_keys_str_mv | AT ortizernesto scorpionvenomcomponentsaspotentialcandidatesfordrugdevelopment AT gurrolageorginab scorpionvenomcomponentsaspotentialcandidatesfordrugdevelopment AT schwartzelisabethferroni scorpionvenomcomponentsaspotentialcandidatesfordrugdevelopment AT possanilourivald scorpionvenomcomponentsaspotentialcandidatesfordrugdevelopment |